Yahoo Finance

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is designed ...
PharmTech

The New EMA Bioequivalence Guideline: Key Considerations

A new guideline for conducting bioequivalence studies was adopted by the CPMP in January and it becomes fully effective as of August 2010. A new guideline 1 for conducting bioequivalence studies was ...
Business Wire

Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator™ Module

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods ...
Pharmabiz

IPC successfully concludes WHO Biowaiver Project for BCS based classification of APIs

The Indian Pharmacopoeia Commission (IPC) has successfully participated and concluded World Health Organisation (WHO) Biowaiver Project for Biopharmaceutics Classification System (BCS) based ...
Stockhouse

Certara introduces Simcyp(TM) Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is designed ...
Finanznachrichten

Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp Biopharmaceutics software. It is designed ...